awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30663777-B95F699E-6CC7-4744-89BC-A005C353484A
Q30663777-B95F699E-6CC7-4744-89BC-A005C353484A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30663777-B95F699E-6CC7-4744-89BC-A005C353484A
Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy
P2860
Q30663777-B95F699E-6CC7-4744-89BC-A005C353484A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30663777-B95F699E-6CC7-4744-89BC-A005C353484A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5190b9c562cd68ca73b0d994040fa5bfe66c888a
P2860
Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal.